VISION
Most important of all toxicity testing is neurotoxicity assessment to prove the new drug is neuro-safe. The classical example of thalidomide The development of a new drug involves various phases of preclinical and clinical research. Toxicological studies provide essential details on toxic effects. Avoiding toxicity and minimizing unavoidable side effects are very essential in introducing a new drug. Most important of all toxicity testing is neurotoxicity assessment to prove the new drug is neuro-safe. The classical example of thalidomide toxicity exemplifies the significance of neurosafety evaluation. Our vision of promoting health care by neurosafe drugs and nutraceuticals can be accomplished through preclinical neurotoxicity testing by advanced techniques and appropriate evaluation procedures.
Most important of all toxicity testing is neurotoxicity assessment to prove the new drug is neuro-safe. The classical example of thalidomide The development of a new drug involves various phases of preclinical and clinical research. Toxicological studies provide essential details on toxic effects. Avoiding toxicity and minimizing unavoidable side effects are very essential in introducing a new drug. Most important of all toxicity testing is neurotoxicity assessment to prove the new drug is neuro-safe. The classical example of thalidomide toxicity exemplifies the significance of neurosafety evaluation. Our vision of promoting health care by neurosafe drugs and nutraceuticals can be accomplished through preclinical neurotoxicity testing by advanced techniques and appropriate evaluation procedures.